Table 1.

Drinking risk level at baseline and month 6 from two 6-month double-blind randomized controlled trials.

Time point	Women (n = 217)		Men (n = 424)
Drinking risk level	Placebo	Nalmefene	Placebo	Nalmefene
Baseline
High	25	29	109	91
Very high	86	77	102	122
Month 6
Abstinence or low	30	33	71	96
Medium or above	81	73	140	117

Note: Drinking risk level (DRL, low, medium, high, very high) as defined in the Methods section. Missing values were handled using the last observation carried forward.